抗血管内皮生长因子单克隆抗体Bevacizumab玻璃体腔注射治疗高度近视脉络膜新生血管的疗效观察_Chinese Journal of Ocular Fundus Diseases

Chinese Journal of Ocular Fundus Diseases

Supervisor：China Association for Science and Technology Sponsor：Chinese Medical Association
Editor-in-chief：Li Xiaoxin
Publishing period： Monthly ISSN：1005-1015 CN：51-1434/R

抗血管内皮生长因子单克隆抗体Bevacizumab玻璃体腔注射治疗高度近视脉络膜新生血管的疗效观察

Chinese Journal of Ocular Fundus Diseases | 2008, 24(3): 218-219
First online：

Article Views：2924
PDF Downloads：420
Cited by：0

Authors：

Hong Yin Xiaoxin Li

Department of Ophthalmology, People′;
s Hospital of Peking University;

Corresponding author：

Keywords：

脉络膜新生血管化/药物疗法; 近视; 退行性/药物疗法; 抗体; 单克隆/治疗应用; Bevacizumab

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Hong Yin Xiaoxin Li. 抗血管内皮生长因子单克隆抗体Bevacizumab玻璃体腔注射治疗高度近视脉络膜新生血管的疗效观察. Chinese Journal of Ocular Fundus Diseases, 2008, 24(3): 218-219. doi: Copy

Chinese Journal of Ocular Fundus Diseases

抗血管内皮生长因子单克隆抗体Bevacizumab玻璃体腔注射治疗高度近视脉络膜新生血管的疗效观察

Abstract Full text Figures/Tables Video References Cited by

Format

Content